Literature DB >> 19064272

Inhibition of woodchuck hepatitis virus gene expression in primary hepatocytes by siRNA enhances the cellular gene expression.

Zhongji Meng1, Song Qiu, Xiaoyong Zhang, Jun Wu, Thomas Schreiter, Yang Xu, Dongliang Yang, Michael Roggendorf, Jörg Schlaak, Mengji Lu.   

Abstract

Small interfering RNA (siRNA) has been shown to be active to inhibit the hepatitis B virus gene expression and replication in transient and stable transfection systems. Here in primary hepatocytes prepared from naturally woodchuck hepatitis virus (WHV)-infected woodchucks, four siRNAs targeting the WHV preS1, S, C, and X region led to a depletion of WHV transcripts and replicative intermediates with different kinetics and a decreased production of viral particles. Two siRNAs targeting WHV S and X region had the highest efficacy to deplete 70% of WHV transcripts and replicative intermediates. In addition, siRNA-mediated suppression of WHV enhanced the expression of cellular genes like MxA and MHC I. Specific siRNAs are able to inhibit the hepadnaviral replication and enhance the expression of cellular genes relevant for antiviral actions. Thus, siRNAs might be useful as novel antiviral agents for the treatment of chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19064272     DOI: 10.1016/j.virol.2008.11.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

Review 1.  The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.

Authors:  Michael Roggendorf; Anna D Kosinska; Jia Liu; Mengji Lu
Journal:  Cold Spring Harb Perspect Med       Date:  2015-10-28       Impact factor: 6.915

2.  Novel Woodchuck Hepatitis Virus (WHV) transgene mouse models show sex-dependent WHV replicative activity and development of spontaneous immune responses to WHV proteins.

Authors:  Zhongji Meng; Zhiyong Ma; Ejuan Zhang; Anna D Kosinska; Jia Liu; Xiaoyong Zhang; Tianlun Zhou; Jun Wu; Uta Dahmen; Olaf Dirsch; Dongliang Yang; Michael Roggendorf; Mengji Lu
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

3.  Potential genetic robustness of Prnp and Sprn double knockout mouse embryos towards ShRNA-lentiviral inoculation.

Authors:  Andrea Rau; Bruno Passet; Johan Castille; Nathalie Daniel-Carlier; Alexandre Asset; Jérome Lecardonnel; Marco Moroldo; Florence Jaffrézic; Denis Laloë; Katayoun Moazami-Goudarzi; Jean-Luc Vilotte
Journal:  Vet Res       Date:  2022-07-07       Impact factor: 3.829

Review 4.  Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck.

Authors:  Anna D Kosinska; Jia Liu; Mengji Lu; Michael Roggendorf
Journal:  Med Microbiol Immunol       Date:  2014-12-23       Impact factor: 3.402

5.  Inhibition of hepatitis B virus (HBV) gene expression and replication by HBx gene silencing in a hydrodynamic injection mouse model with a new clone of HBV genotype B.

Authors:  Lei Li; Hong Shen; Anyi Li; Zhenhua Zhang; Baoju Wang; Junzhong Wang; Xin Zheng; Jun Wu; Dongliang Yang; Mengji Lu; Jingjiao Song
Journal:  Virol J       Date:  2013-06-28       Impact factor: 4.099

Review 6.  RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant?

Authors:  Zhongji Meng; Mengji Lu
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

Review 7.  Recent Drug Development in the Woodchuck Model of Chronic Hepatitis B.

Authors:  Manasa Suresh; Stephan Menne
Journal:  Viruses       Date:  2022-08-03       Impact factor: 5.818

8.  RNAi induces innate immunity through multiple cellular signaling pathways.

Authors:  Zhongji Meng; Xiaoyong Zhang; Jun Wu; Rongjuan Pei; Yang Xu; Dongliang Yang; Michael Roggendorf; Mengji Lu
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

9.  Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.

Authors:  Zhi-Qiang Wei; Yong-Hong Zhang; Chang-Zheng Ke; Hong-Xia Chen; Pan Ren; Yu-Lin He; Pei Hu; De-Qiang Ma; Jie Luo; Zhong-Ji Meng
Journal:  World J Gastroenterol       Date:  2017-09-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.